Answers are grounded in this paper and cite their sources.
WaterborneEscherichia coliare a major reservoir of antimicrobial resistance (AMR), including but not limited to extended-spectrum beta-lactamase (ESBL) andKlebsiella pneumoniaecarbapenemase (KPC) mechanisms. This study quantified and described ESBL- and KPC-producingE. coliin Northern Colorado from sewer water, surface water, and influent and effluent wastewater treatment sources. Total detected bacteria andE. coliabundances, and the percentages that contain ESBL and/or KPC, were compared between water sources. SeventyE. coliisolates from the various waters had drug resistance validated with a panel of 17 antibiotics using a broth microdilution assay. The diverse drug resistance observed acrossE. coliisolates was further documented by polymerase chain reaction of common ESBL genes and functional relatedness by PhenePlate assay-generated dendrograms ( n=70 ). The totalE. coliabundance decreased through the water treatment process as expected, yet the percentages ofE. coliharboring ESBL resistance were increased (1.70%) in surface water. Whole-genome sequencing analysis was completed for 185 AMR genes in wastewaterE. coliisolates and confirmed the presence of diverse AMR gene classes (e.g., beta-lactams and efflux pumps) in isolate genomes. This study completed surveillance of AMR patterns inE. colithat reside in environmental water systems and suggests a role for integrating both phenotypic and genotypic profiling beyond ESBL and KPC mechanisms. AMR screening via multiple approaches may assist in the prevention of drug-resistantE. colispread from waters to animals and humans.
No takes yet. Share an insight, caveat, or question.
Haberecht et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: